Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2017 Apr 1.

Published in final edited form as: Ann Allergy Asthma Immunol. 2016 Jan 25;116(4):321–328.e1. doi: 10.1016/j.anai.2015.12.026

FEV1 and NPF change after 40 mg aspirin and after standard oral graded aspirin challenge. 3a and 3c. In AERD patients after 40 mg aspirin challenge, there was no significant decrease in FEV1 or in NPF. There was a significant decrease in FEV1 (p=0.03) and in NPF (p=0.001) after graded aspirin challenge. 3b and 3d. In ATA patients there was no significant change in FEV1 or in NPF after 40 mg aspirin or after graded aspirin challenge.

FEV1 and NPF change after 40 mg aspirin and after standard oral graded aspirin challenge. 3a and 3c. In AERD patients after 40 mg aspirin challenge, there was no significant decrease in FEV1 or in NPF. There was a significant decrease in FEV1 (p=0.03) and in NPF (p=0.001) after graded aspirin challenge. 3b and 3d. In ATA patients there was no significant change in FEV1 or in NPF after 40 mg aspirin or after graded aspirin challenge.